TrialAnnals of hematology2020

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.

Heiko Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.